Soleno Therapeutics (SLNO) Receivables - Net (2016 - 2017)
Historic Receivables - Net for Soleno Therapeutics (SLNO) over the last 5 years, with Q2 2017 value amounting to $3000.0.
- Soleno Therapeutics' Receivables - Net fell 9895.83% to $3000.0 in Q2 2017 from the same period last year, while for Jun 2017 it was $3000.0, marking a year-over-year decrease of 9895.83%. This contributed to the annual value of $3000.0 for FY2016, which is 9807.85% down from last year.
- Latest data reveals that Soleno Therapeutics reported Receivables - Net of $3000.0 as of Q2 2017, which was down 9895.83% from $110000.0 recorded in Q1 2017.
- Over the past 5 years, Soleno Therapeutics' Receivables - Net peaked at $288000.0 during Q2 2016, and registered a low of $3000.0 during Q4 2016.
- Its 5-year average for Receivables - Net is $98727.7, with a median of $102000.0 in 2015.
- As far as peak fluctuations go, Soleno Therapeutics' Receivables - Net soared by 230000.0% in 2016, and later tumbled by 9895.83% in 2017.
- Over the past 5 years, Soleno Therapeutics' Receivables - Net (Quarter) stood at $149605.0 in 2013, then tumbled by 75.27% to $37000.0 in 2014, then skyrocketed by 321.96% to $156127.0 in 2015, then crashed by 98.08% to $3000.0 in 2016, then changed by 0.0% to $3000.0 in 2017.
- Its Receivables - Net stands at $3000.0 for Q2 2017, versus $110000.0 for Q1 2017 and $3000.0 for Q4 2016.